DGAP-Adhoc: BRAIN Biotech AG: Successful Genome Editing Activity in Mammalian Cells with BRAIN-Metagenome-Cas (BMC), BRAIN-Engineered-Cas (BEC)

DGAP-Ad-hoc: BRAIN Biotech AG / Key word(s): Miscellaneous
BRAIN Biotech AG: Successful Genome Editing Activity in Mammalian Cells with BRAIN-Metagenome-Cas (BMC), BRAIN-Engineered-Cas (BEC)

04-Apr-2022 / 10:31 CET/CEST
Disclosure of an inside...
Quelle: Börse Online RSS Feed